See more : MBX Biosciences, Inc. Common Stock (MBX) Income Statement Analysis – Financial Results
Complete financial analysis of Scientific Brain Training SA (MLSBT.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Scientific Brain Training SA, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Azimut Exploration Inc. (AZM.V) Income Statement Analysis – Financial Results
- Pentamaster International Limited (1665.HK) Income Statement Analysis – Financial Results
- High Fashion International Limited (0608.HK) Income Statement Analysis – Financial Results
- SoftBank Corp. (SFBQF) Income Statement Analysis – Financial Results
- Atal Realtech Limited (ATALREAL.BO) Income Statement Analysis – Financial Results
Scientific Brain Training SA (MLSBT.PA)
About Scientific Brain Training SA
Scientific Brain Training SA provides consultancy and human resources, and smart health services for individuals and the healthcare sector. The company provides services for the selection level of behavioral competencies, such as managerial, commercial, and operational; and advice and support training services. It also offers software solutions for healthcare professions to treat and prevent cognitive and learning disorders; and cognition and neurotraumatic, neurodegenerative, and neuropsychiatric disorders solutions for children, teenagers, adults, and seniors. Scientific Brain Training SA was founded in 2000 and is based in Lyon, France.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.90M | 14.11M | 13.61M | 12.17M | 11.27M | 10.18M | 8.78M | 6.94M | 5.40M | 5.18M | 4.45M | 3.22M | 4.05M | 3.07M |
| Cost of Revenue | 520.98K | 1.35M | 1.36M | 1.08M | 854.11K | 741.48K | 2.38M | 1.75M | 1.81M | 1.26M | 9.80K | 11.90K | -183.10K | -109.90K |
| Gross Profit | 12.38M | 12.76M | 12.26M | 11.09M | 10.42M | 9.44M | 6.40M | 5.20M | 3.58M | 3.92M | 4.45M | 3.21M | 4.24M | 3.18M |
| Gross Profit Ratio | 95.96% | 90.44% | 90.01% | 91.15% | 92.42% | 92.72% | 72.90% | 74.81% | 66.39% | 75.68% | 99.78% | 99.63% | 104.52% | 103.57% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 927.24K | 1.06M | 946.54K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 230.21K | 257.46K | 323.44K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.65M | 1.30M |
| SG&A | 1.16M | 1.32M | 1.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.65M | 1.30M |
| Other Expenses | 11.32M | 11.02M | 10.60M | 10.49M | 9.75M | 9.21M | 5.78M | 5.20M | 3.77M | 3.91M | 4.36M | 3.91M | 2.82M | 2.19M |
| Operating Expenses | 12.48M | 12.34M | 11.87M | 10.49M | 9.75M | 9.21M | 5.78M | 5.20M | 3.77M | 3.91M | 4.36M | 3.91M | 4.47M | 3.49M |
| Cost & Expenses | 13.00M | 13.69M | 13.23M | 11.57M | 10.61M | 9.95M | 8.16M | 6.95M | 5.59M | 5.17M | 4.37M | 3.92M | 4.29M | 3.38M |
| Interest Income | 0.00 | 0.00 | 0.00 | 120.16K | 20.29K | 0.00 | 253.30K | 0.00 | 0.00 | 0.00 | 75.70K | 35.20K | 417.30K | 356.20K |
| Interest Expense | 2.89K | 5.75K | 7.79K | 46.94K | 14.72K | -24.92K | 31.60K | 0.00 | -15.40K | -1.40K | 9.90K | 21.10K | 94.90K | 50.30K |
| Depreciation & Amortization | 713.66K | 877.72K | 777.69K | 576.89K | 502.08K | 885.99K | 986.20K | 928.80K | 655.20K | 753.10K | 867.80K | 659.30K | 1.35M | 574.10K |
| EBITDA | -116.06K | 1.00M | 969.96K | 1.23M | 1.18M | 1.03M | 1.08M | 61.90K | 214.50K | 238.60K | 353.10K | -944.40K | 383.80K | 724.50K |
| EBITDA Ratio | -0.90% | 7.12% | 7.12% | 10.12% | 10.44% | 10.14% | 12.32% | 0.89% | 3.97% | 4.60% | 7.93% | -29.34% | 9.47% | 23.57% |
| Operating Income | -829.72K | 126.54K | 192.27K | 654.83K | 675.08K | 147.09K | 95.40K | -866.90K | -440.70K | -514.50K | -514.70K | -1.60M | -961.50K | 150.40K |
| Operating Income Ratio | -6.43% | 0.90% | 1.41% | 5.38% | 5.99% | 1.44% | 1.09% | -12.48% | -8.16% | -9.93% | -11.55% | -49.83% | -23.73% | 4.89% |
| Total Other Income/Expenses | -2.89K | -5.75K | -7.79K | -46.63K | -14.06K | 24.92K | 396.60K | 0.00 | 15.40K | 1.40K | -9.90K | -21.10K | 1.05M | -148.20K |
| Income Before Tax | -832.61K | 120.79K | 184.48K | 608.20K | 661.01K | 172.01K | 492.00K | -866.90K | -425.30K | -513.10K | -524.60K | -1.62M | 86.30K | 2.20K |
| Income Before Tax Ratio | -6.45% | 0.86% | 1.35% | 5.00% | 5.86% | 1.69% | 5.60% | -12.48% | -7.88% | -9.90% | -11.78% | -50.49% | 2.13% | 0.07% |
| Income Tax Expense | -224.43K | -48.00K | -13.28K | 42.68K | 155.42K | -128.18K | 162.70K | -203.20K | -124.70K | -109.30K | -348.80K | -298.30K | 10.30K | 31.90K |
| Net Income | -608.19K | 168.79K | 197.76K | 565.51K | 505.60K | 300.18K | 329.30K | -663.70K | -300.60K | -403.80K | -175.80K | -1.33M | 76.00K | -29.70K |
| Net Income Ratio | -4.71% | 1.20% | 1.45% | 4.65% | 4.49% | 2.95% | 3.75% | -9.56% | -5.57% | -7.79% | -3.95% | -41.22% | 1.88% | -0.97% |
| EPS | -0.31 | 0.08 | 0.10 | 0.28 | 0.25 | 0.15 | 0.17 | -0.34 | -0.15 | -0.20 | -0.09 | -0.68 | 0.04 | -0.02 |
| EPS Diluted | -0.31 | 0.08 | 0.10 | 0.28 | 0.25 | 0.15 | 0.17 | -0.34 | -0.15 | -0.20 | -0.09 | -0.68 | 0.04 | -0.02 |
| Weighted Avg Shares Out | 1.98M | 2.11M | 1.98M | 2.02M | 2.02M | 1.97M | 1.98M | 1.98M | 1.98M | 1.98M | 1.95M | 1.95M | 1.87M | 1.71M |
| Weighted Avg Shares Out (Dil) | 1.98M | 2.11M | 1.98M | 2.02M | 2.02M | 1.97M | 1.98M | 1.98M | 1.98M | 1.98M | 1.95M | 1.95M | 1.87M | 1.71M |
Source: https://incomestatements.info
Category: Stock Reports